[Experimental Study on Neonatal ABO or RhD Compatible Blood Transfusion].

Area of Science:

• Neonatal Medicine
• Transfusion Medicine
• Immunology

Background:

• Neonatal blood transfusions require careful consideration of blood group compatibility to ensure safety and efficacy.
• ABO or Rh(D) compatible blood transfusion is an alternative to type-matched transfusion in neonates.
• Limited data exists on the comparative safety and effectiveness of these transfusion methods in neonates.

Purpose of the Study:

• To investigate the safety and effectiveness of neonatal ABO or Rh(D) compatible blood transfusion.
• To compare compatible blood transfusion with type-matched blood transfusion in neonates.
• To analyze retrospective data on neonatal transfusion outcomes.

Main Methods:

• Retrospective analysis of 26 neonatal compatible blood transfusions and 26 type-matched transfusions (1:1 ratio).
• Collected clinical data included patient characteristics, red blood cell (RBC) count, hemoglobin (Hb), and hematocrit (Hct).
• Safety assessed via Hb, indirect bilirubin (IBiL), irregular antibody screening, direct antiglobulin test (DAT), and adverse reactions.

Main Results:

• No significant differences in age, sex, or hospitalization days between groups.
• Similar pre-transfusion Hb, transfusion volume, and post-transfusion increases in Hb, Hct, and RBC.
• No adverse reactions; compatible transfusion group showed decreased IBiL; no new antibodies detected; DAT negative except in cases of neonatal hemolysis.

Conclusions:

• Neonatal compatible blood transfusion demonstrates equivalent safety and effectiveness compared to type-matched transfusion.
• Compatible blood transfusion is a safe and effective option for clinical use in neonates.
• Further research may explore specific indications and long-term outcomes.